A bipartisan report issued December 15 by the US Senate Special Committee on Aging outlined a series of policy recommendations aimed at increasing the use of generic drugs within the Medicare Part D program.
Nearly 41 million beneficiaries were enrolled in Medicare Part D for the 2014 plan year, according to the report (http://1.usa.gov/1AXhxMb). Under the program, which accounts for more than 10% of total Medicare costs, private health insurers vie for Medicare beneficiaries by offering competitively priced drug coverage programs.
Rubin R. Senate Committee on Aging Proposes Ways to Expand Generics Use. JAMA. 2015;313(6):558. doi:10.1001/jama.2015.179